Market cap
$163 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -2.80 | -77.54 | -98.47 | -78.64 | -- |
| EBIT | 75.48 | 94.59 | 24.02 | -136.02 | -- |
| Net Profit | 60.07 | 92.98 | 33.19 | -56.27 | -- |
| EPS | -- | -- | 61.86 | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-21 | Dec-20 |
| EBIT-Margin
| -6,398.79 | -- | -15,251.46 | -18,836.81 | -262.66 |
| Net Margin
| 68.89 | -- | 376.16 | 527.31 | -389.54 |
| Return on equity
| 234.84 | -- | -- | 257.76 | 201.74 |
| Return on Capital
| 532.74 | -- | -- | 3,501.69 | -645.88 |
| Return on Assets
| -158.00 | -- | -90.97 | -187.95 | -150.31 |
| Debt to Equity (x)
| -- | -- | -1.32 | -- | -1.66 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
3,501.69
|
-645.88
|
-1,257.59
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
257.76
|
201.74
|
245.01
|
--
|
|
Peer Median
|
-26.31
|
--
|
--
|
--
|
--
|
ROA
-90.97
Lower than Peers by 78.01
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-90.97
|
-187.95
|
-150.31
|
-135.74
|
--
|
|
Peer Median
|
-12.96
|
--
|
--
|
--
|
--
|
EBIT Margin
-15,251.46
Lower than Peers by 15,191.76
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-15,251.46
|
-18,836.81
|
-262.66
|
-96.92
|
-89.68
|
|
Peer Median
|
-59.70
|
--
|
--
|
--
|
--
|
Net Margin
376.16
Higher than Peers by 447.22
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
376.16
|
527.31
|
-389.54
|
-102.81
|
-100.88
|
|
Peer Median
|
-71.06
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.02
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-0.02
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-98.47
Lower than Peers by 119.03
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-98.47
|
-0.98
|
-0.48
|
0.13
|
--
|
|
Peer Median
|
20.56
|
--
|
--
|
--
|
--
|
EBIT Growth
24.02
Higher than Peers by 8.82
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
24.02
|
-20.34
|
-39.88
|
-21.59
|
--
|
|
Peer Median
|
15.20
|
--
|
--
|
--
|
--
|
Net Profit Growth
33.19
Higher than Peers by 25.32
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
33.19
|
-28.51
|
-30.05
|
-14.66
|
--
|
|
Peer Median
|
7.86
|
--
|
--
|
--
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
0.62
|
0.07
|
--
|
--
|
|
Peer Median
|
30.45
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-1.32
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-1.32
|
--
|
-1.66
|
-0.87
|
-1.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.06
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-0.06
|
-0.22
|
-0.01
|
0.00
|
-0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.48
Lower than Peers by 2.00
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
1.48
|
1.60
|
1.74
|
0.74
|
1.14
|
|
Peer Median
|
3.48
|
--
|
--
|
--
|
--
|
Quick Ratio
1.48
Lower than Peers by 1.81
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
1.48
|
--
|
1.57
|
0.63
|
1.04
|
|
Peer Median
|
3.29
|
--
|
--
|
--
|
--
|
Interest Coverage
-10.33
Lower than Peers by 8.82
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
-10.33
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-1.51
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
82.11
Higher than Peers by 57.78
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
82.11
|
52.37
|
17.07
|
15.85
|
6.37
|
|
Peer Median
|
24.33
|
--
|
--
|
--
|
--
|
Asset Turnover
0.01
Lower than Peers by 0.22
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
0.01
|
0.01
|
0.58
|
1.32
|
--
|
|
Peer Median
|
0.23
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
1,952.93
|
87.25
|
39.28
|
23.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
--
|
45.26
|
33.72
|
30.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
--
|
64.82
|
48.68
|
43.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
--
|
67.69
|
24.31
|
9.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
-1.40
|
-1.36
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
-4.08
|
-2.45
|
--
|
--
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
--
|
-1.11
|
-1.83
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
163
Higher than Peers by 80
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Biora Therapeutics Inc (BIOR)
|
163
|
--
|
--
|
--
|
--
|
|
Peer Median
|
83
|
--
|
--
|
--
|
--
|